Top Clinical News Stories Last Month

The most viewed clinical news stories last month included the release of a brand new coagulometer, the latest articles from The Binding Site's International Symposium and the launch of a new next generation sequencing test. 

1. Siemens Healthcare Diagnostics Launches Xprecia Stride Coagulation Analyzer

Siemens Healthcare Diagnostics introduced a first-of-its-kind, hand-held portable coagulation analyzer. The Xprecia Stride Coagulation Analyzer delivers fast, reliable Prothrombin time testing (PT/INR) for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist.

2. 7 Hot New Technologies for Cancer Research

Read the latest news from this year's American Association for Cancer Research (AACR) annual meeting in Philadelphia including a new quantitative imaging system, advances in cloud computing solutions for researchers and the winners of the Life Science Scientists' Choice award® for Best New Life Science Product of 2014.

3. A Polyclonal v Monoclonal Approach to FLC Measurement

There were many interesting talks at the recent Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis International Symposium, held in Edinburgh, UK. Dr Robert Lock, Consultant Clinical Scientist, Immunology & Immunogenetics, North Bristol NHS Trust, UK, addressed the delegation on a Polyclonal v Monoclonal Approach to Free Light Chain (FLC) Measurement. His presentation detailed comparisons between the different monoclonal and polyclonal assays available on the market.

4. Early Detection of Ovarian Cancer: Medical University of Vienna Demonstrates ANGLE’s ‘Blood Biopsy’ Technology

Researchers from the Medical University of Vienna presented a scientific poster at the American Association of Cancer Research Annual meeting, detailing a protocol combining the novel microfluidic Parsortix™ technology with qPCR, to enable the molecular analysis of circulating tumor cells (CTCs) implicated in ovarian and breast cancer. The Parsortix system is currently research use only, and not for use as an in vitro diagnostic.

5. New Study in the Clinical Biochemistry Journal Identifies the Precise Magnitude of Change in Cardiac Troponin Required for Early Diagnosis of a Heart Attack

Beckman Coulter Diagnostics announced the publication of research results in the Clinical Biochemistry journal that identifies the precise magnitude of change in cardiac troponin required for early diagnosis of a heart attack (myocardial infarction, or MI), utilizing its Access AccuTnI+3 troponin I blood test.

6. New Affordable Advanced NGS Cancer Test Launched by EKF Subsidiary

EKF Diagnostics subsidiary, Selah Genomics, announced the launch of its next generation sequencing (NGS) technology PrecisionPath™ in partnership with Greenville Health Systems (GHS), one of the leading community-based cancer Institutes in the US. For the first time, patients will have wider access to affordable advanced NGS testing that can help doctors determine the most effective cancer treatments based on an individual’s genetic profile.

7. 6 Exclusive Clinical Interviews

SelectScience regularly interviews thought-leading scientists from around the world to bring you the latest advances in clinical diagnostics. In this article, we look at the most popular of our recent interviews including discussions on celiac disease, molecular diagnostics in microbiology, and ways of combating the rise of antibiotic resistance.

8. QIAGEN Partners with World’s Largest Sequencing Provider

QIAGEN N.V. recently announced that it has expanded its relationship with BGI, the world’s largest genomics organization, to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services.